Telomerase activation by the E6 gene product of human papillomavirus type 16

Nature
A J KlingelhutzJ K McDougall

Abstract

Activation of telomerase, a ribonucleoprotein complex that synthesizes telomere repeat sequences, is linked to cell immortalization and is characteristic of most cell lines and tumours. Here we show that expression of the human papillomavirus type 16 (HPV-16) E6 protein activates telomerase in early-passage human keratinocytes and mammary epithelial cells. This activation was observed in cells pre-crisis, that is, before they became immortal, and occurred within one passage of retroviral infection with vectors expressing HPV-16 E6. Studies using HPV-16 E6 mutants showed that there was no correlation between the ability of the mutants to activate telomerase and their ability to target p53 for degradation, suggesting that telomerase activation by HPV-16 E6 is p53 independent. Keratinocytes expressing wild-type HPV-16 E6 have an extended lifespan, but do not become immortal, indicating that telomerase activation and E6-mediate degradation of p53 are insufficient for their immortalization. These results show that telomerase activation is an intrinsic, but insufficient, component of transformation by HPV.

References

Nov 1, 1992·Proceedings of the National Academy of Sciences of the United States of America·R C AllsoppC B Harley
Jan 1, 1992·Annual Review of Biochemistry·E H Blackburn
Jun 20, 1992·Journal of Molecular Biology·M Z LevyC B Harley
Mar 1, 1991·Mutation Research·C B Harley
Jan 1, 1991·Mutation Research·J LindseyH J Cooke
May 31, 1990·Nature·C B HarleyC W Greider
Aug 30, 1990·Nature·N D HastieR C Allshire
Sep 1, 1995·Science·J FengJ Yu
Sep 26, 1995·Proceedings of the National Academy of Sciences of the United States of America·D BroccoliT de Lange
Apr 12, 1994·Proceedings of the National Academy of Sciences of the United States of America·C M CounterC B Harley
Feb 1, 1994·Molecular and Cellular Biology·A J KlingelhutzJ K McDougall

❮ Previous
Next ❯

Citations

Nov 26, 1997·The Journal of Pathology·T SuginoS Goodison
Sep 1, 1996·Journal of Cellular Physiology·M B SmallK A Sethi
Jun 11, 1999·Journal of Cellular Physiology·M C MontaltoF A Ray
Mar 27, 2001·International Journal of Cancer. Journal International Du Cancer·G B WismanA G van der Zee
Sep 25, 2004·International Journal of Cancer. Journal International Du Cancer·Fu ChenIngemar Ernberg
Dec 25, 2012·Archives of Gynecology and Obstetrics·Qiong CaiAiping Dian
Feb 16, 2005·Apoptosis : an International Journal on Programmed Cell Death·Xueli FanJason J Chen
Mar 24, 2005·Cancer Metastasis Reviews·Zoltán SzentirmayMiklós Kásler
Oct 20, 2009·Virus Genes·Raffaella GhittoniMassimo Tommasino
May 12, 2009·Journal of Biosciences·Niladri Ganguly, Suraj P Parihar
Jun 28, 2007·Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico·A González Martín
May 22, 2008·Pathology Oncology Research : POR·Ioannis N MammasDemetrios A Spandidos
Sep 1, 1996·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·R G BristowR P Hill
Oct 9, 1996·Biochimica Et Biophysica Acta·H zur Hausen
Apr 30, 2013·Cancer Letters·E Susan AmirianMichael E Scheurer
May 28, 2004·Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology·Torsten W RemmerbachUwe Gerd Liebert
Jan 7, 2004·Mechanisms of Ageing and Development·Hyun Tae KangEun Seong Hwang
May 5, 2005·Urologic Oncology·Antonio M Serafin, Lothar Bohm
Jun 12, 2002·The American Journal of Pathology·Renske D M SteenbergenPeter J F Snijders
Dec 16, 1997·Obstetrics and Gynecology·G H Eltabbakh
Feb 20, 1998·Obstetrics and Gynecology·T IwasakaH Sugimori
Dec 10, 2002·Mechanisms of Ageing and Development·Eun Seong Hwang
Oct 1, 1996·Mutation Research·C M Counter
Mar 27, 2001·Biochimica Et Biophysica Acta·D L Crowe, D C Nguyen
Nov 26, 2002·Virus Research·Karl Münger, Peter M Howley
May 1, 1999·Trends in Genetics : TIG·C W Greider
May 22, 2003·Cancer Letters·Martha R Stampfer, Paul Yaswen
Sep 18, 1998·Biochimica Et Biophysica Acta·L Rapp, J J Chen
Mar 1, 1997·Clinics in Dermatology·L Crawford, M Tommasino
Oct 2, 1998·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·G Mathé
Oct 6, 1999·Current Opinion in Biotechnology·T R Yeager, R R Reddel
Apr 1, 1997·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·T M Bryan, R R Reddel
Dec 16, 1998·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·M BisoffiJ K Griffith
Mar 10, 1999·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·K KawaiM Ishikawa
Apr 22, 1999·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·D K ZhangS W Tsao
Jan 1, 1998·The Veterinary Journal·M S Campo
Apr 28, 2001·Cytokine & Growth Factor Reviews·A E KoromilasG Matlashewski
May 5, 2001·Oral Oncology·T Sumida, H Hamakawa
Jan 29, 2000·Mutation Research·C Cerni

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.